about
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. ...
Read More
1.67
-0.06
(-3.47%)
45,165.2
XNAS Volume
XNAS 21 Sep, 2026 4:06 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
MetaVia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..